Kathrin Tintelnot

4.0k total citations
117 papers, 2.5k citations indexed

About

Kathrin Tintelnot is a scholar working on Epidemiology, Infectious Diseases and Cell Biology. According to data from OpenAlex, Kathrin Tintelnot has authored 117 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Epidemiology, 78 papers in Infectious Diseases and 25 papers in Cell Biology. Recurrent topics in Kathrin Tintelnot's work include Fungal Infections and Studies (80 papers), Antifungal resistance and susceptibility (75 papers) and Nail Diseases and Treatments (29 papers). Kathrin Tintelnot is often cited by papers focused on Fungal Infections and Studies (80 papers), Antifungal resistance and susceptibility (75 papers) and Nail Diseases and Treatments (29 papers). Kathrin Tintelnot collaborates with scholars based in Germany, Netherlands and Switzerland. Kathrin Tintelnot's co-authors include Michael Seibold, Sybren de Hoog, Gerhard Haase, Volker Rickerts, Karin Lemmer, Massimo Cogliati, G. Just‐Nübling, Aristea Velegraki, Uwe Groß and A. H. G. Gerrits van den Ende and has published in prestigious journals such as The Lancet, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Kathrin Tintelnot

113 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathrin Tintelnot Germany 28 1.7k 1.7k 671 420 323 117 2.5k
Liyan Xi China 27 1.2k 0.7× 1.6k 1.0× 863 1.3× 417 1.0× 355 1.1× 123 2.4k
Catriona Halliday Australia 34 2.2k 1.3× 2.1k 1.2× 811 1.2× 319 0.8× 458 1.4× 100 3.0k
Dea Garcia‐Hermoso France 27 2.1k 1.2× 1.9k 1.1× 505 0.8× 352 0.8× 368 1.1× 79 2.6k
Ricardo Negroni Argentina 27 2.1k 1.2× 2.6k 1.5× 593 0.9× 384 0.9× 371 1.1× 238 3.1k
Yvonne R. Shea United States 22 1.6k 0.9× 1.7k 1.0× 423 0.6× 212 0.5× 692 2.1× 35 2.4k
Ángela Restrepo Colombia 32 2.6k 1.5× 3.3k 1.9× 735 1.1× 502 1.2× 482 1.5× 95 3.9k
Birgit Spieß Germany 25 1.6k 0.9× 1.5k 0.9× 434 0.6× 285 0.7× 297 0.9× 51 2.0k
Marcel Wüthrich United States 33 1.7k 1.0× 1.8k 1.1× 226 0.3× 435 1.0× 228 0.7× 75 3.0k
E. Guého France 30 1.1k 0.6× 2.2k 1.3× 1.6k 2.4× 733 1.7× 305 0.9× 74 3.3k
Miki Kasai United States 18 912 0.5× 711 0.4× 350 0.5× 198 0.5× 135 0.4× 21 1.5k

Countries citing papers authored by Kathrin Tintelnot

Since Specialization
Citations

This map shows the geographic impact of Kathrin Tintelnot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Tintelnot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Tintelnot more than expected).

Fields of papers citing papers by Kathrin Tintelnot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Tintelnot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Tintelnot. The network helps show where Kathrin Tintelnot may publish in the future.

Co-authorship network of co-authors of Kathrin Tintelnot

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Tintelnot. A scholar is included among the top collaborators of Kathrin Tintelnot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Tintelnot. Kathrin Tintelnot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sedlacek, Ludwig, Barbara Graf, C. Schwarz, et al.. (2015). Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium. Journal of Cystic Fibrosis. 14(2). 237–241. 72 indexed citations
3.
Schwarz, C., Anja Thronicke, Doris Staab, & Kathrin Tintelnot. (2015). Scedosporium apiospermum: a fungal pathogen causing pneumonia in a patient with cystic fibrosis. JMM Case Reports. 2(3). 8 indexed citations
4.
Müller, Carsten, H. Weißbrodt, Sebastian Suerbaum, et al.. (2013). Successful prevention of scedosporiosis after lung transplantation in a cystic fibrosis patient by combined local and systemic triazole therapy. Medical Mycology Case Reports. 2. 116–118. 10 indexed citations
5.
6.
Tammer, Ina, Kathrin Tintelnot, Ruediger C. Braun‐Dullaeus, et al.. (2011). Infections due to Pseudallescheria/Scedosporium species in patients with advanced HIV disease — a diagnostic and therapeutic challenge. International Journal of Infectious Diseases. 15(6). e422–e429. 23 indexed citations
7.
Hagen, Ferry, Johanna M. Sweere, Kathrin Tintelnot, et al.. (2009). The occurrence of the primary pathogenic yeastCryptococcus gattii in Europe. Mycoses. 52. 57–57. 1 indexed citations
8.
Resch, Markus, Kathinka D. Kurz, Wulf Schneider‐Brachert, et al.. (2009). Extracorporeal membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) in fulminant blastomycosis in Germany. BMJ Case Reports. 2009. bcr0720080392–bcr0720080392. 8 indexed citations
9.
Mousset, Sabine, Gesine Bug, Werner Heinz, Kathrin Tintelnot, & Volker Rickerts. (2009). Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation. Transplant Infectious Disease. 12(3). 261–264. 29 indexed citations
10.
Müller, Dominik N., et al.. (2008). PCR-based identification of clinically relevant Pseudallescheria/Scedosporium strains. Medical Mycology. 36(2). 61–67. 4 indexed citations
11.
Ashbee, H. R., M.A. Viviani, B. Dupont, et al.. (2008). Histoplasmosis in Europe: Report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Medical Mycology. 46(1). 57–65. 88 indexed citations
12.
Tammer, Ina, et al.. (2006). Successful Topical Therapy with Voriconazole: Pseudallescheriasis After Injury. The Journal of Trauma: Injury, Infection, and Critical Care. 62(5). 1295–1297. 9 indexed citations
13.
Hafner, Christian, H.‐J. Linde, Thomas Vogt, et al.. (2005). Primary Cutaneous Cryptococcosis and Secondary Antigenemia in a Patient with Long-Term Corticosteroid Therapy. Infection. 33(2). 86–89. 19 indexed citations
14.
Meier, Friedegund, et al.. (2004). Kokzidioidomykose. Der Hautarzt. 55(12). 1143–1149. 5 indexed citations
15.
16.
Tintelnot, Kathrin, et al.. (2002). Histoplasmose-Gruppenerkrankung bei Fledermausforschern nach Kubaaufenthalt. DMW - Deutsche Medizinische Wochenschrift. 127(01/02). 21–25. 18 indexed citations
17.
Weig, Michael, Matthias Frosch, Kathrin Tintelnot, et al.. (2001). Use of Recombinant Mitogillin for Improved Serodiagnosis of Aspergillus fumigatus -Associated Diseases. Journal of Clinical Microbiology. 39(5). 1721–1730. 45 indexed citations
18.
Müller, Dominik N., et al.. (1998). PCR-based identification of clinically relevant Pseudallescheria/Scedosporium strains. Medical Mycology. 36(2). 61–67. 5 indexed citations
19.
Bartz‐Schmidt, Karl Ulrich, et al.. (1996). Chronic basidiomycetous endophthalmitis after extracapsular cataract extraction and intraocular lens implantation. Graefe s Archive for Clinical and Experimental Ophthalmology. 234(9). 591–593. 19 indexed citations
20.
Tintelnot, Kathrin & H. P. R. Seeliger. (1988). Aktuelle Gesichtspunkte zur Epidemiologie der Aspergillose*. Actual Aspects on the Epidemiology of Aspergillosis. Mycoses. 31(5). 245–254. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liyan Xi Breakdown of academic impact, for papers by Catriona Halliday Breakdown of academic impact, for papers by Dea Garcia‐Hermoso Breakdown of academic impact, for papers by Ricardo Negroni Breakdown of academic impact, for papers by Yvonne R. Shea Breakdown of academic impact, for papers by Ángela Restrepo Breakdown of academic impact, for papers by Birgit Spieß Breakdown of academic impact, for papers by Marcel Wüthrich Breakdown of academic impact, for papers by E. Guého Breakdown of academic impact, for papers by Miki Kasai
Rankless by CCL
2026